Target intelligence / Profile preview

Gastric luminal contents and gas–liquid interface at the gastro-esophageal junction (GEJ interface)

Target
GEJ interface
Molecular classification
Physical interface, Anatomical site
01

Overview

The gastric luminal contents and the gas–liquid interface at the gastro-esophageal junction (GEJ) represent a physiological and physical environment rather than a specific molecular receptor or enzyme. This site is the primary location of the "acid pocket," a phenomenon where a layer of unbuffered, highly acidic gastric juice (pH ~1.5) sits on top of the ingested meal postprandially [PMID: 23510145]. Because this pocket is positioned near the GEJ, it serves as the main reservoir for acid reflux into the esophagus, particularly in patients with hiatal hernias or weak lower esophageal sphincters [PMID: 11069577]. Therapeutic intervention at this interface is achieved through raft-forming agents, most notably alginates. Upon contact with gastric acid, alginates precipitate into a low-density, pH-neutral gel (a "raft") that incorporates carbon dioxide bubbles, allowing it to float specifically at the gas–liquid interface [PMID: 22222325]. This raft acts as a physical barrier that prevents the reflux of acid, pepsin, and bile into the esophagus, or is refluxed itself in place of the acidic contents [PMID: 24630392]. Unlike systemic medications like proton pump inhibitors that alter gastric pH globally, targeting this interface provides a localized, mechanical solution to the symptoms of gastroesophageal reflux disease (GERD).

Other names
Acid pocketPostprandial acid pocketGastric gas–liquid interfaceGEJ acid reservoir
02

Mechanism of action

Formation of a physical pH-neutral raft that floats on the gastric contents to mechanically block reflux.

03

Biological functions

DigestionAcid containmentGastric secretion
04

Disease associations

Gastroesophageal reflux disease (GERD)Laryngopharyngeal reflux (LPR)Barrett's esophagus
05

Safety considerations

Drug-drug interactions due to altered absorption or chelationSodium loading in patients with hypertension or heart failureCalcium-alkali syndrome with excessive useAspiration of raft material in rare cases
06

Interacting drugs

Sodium alginate

4 more in the full profile.

07

Biomarkers

Postprandial pH at the GEJAcid pocket lengthEsophageal pH-impedance monitoringDeMeester score

Beyond the preview

Go deeper on Gastric luminal contents and gas–liquid interface at the gastro-esophageal junction (GEJ interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric luminal contents and gas–liquid interface at the gastro-esophageal junction (GEJ interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call